NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Editor's Pick

Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

by May 18, 2025
written by May 18, 2025

Former President Joe Biden’s office confirmed on Sunday that he is undergoing treatment for prostate cancer. 

‘Last week, President Joe Biden was seen for a new finding of a prostate nodule after experiencing increasing urinary symptoms,’ Biden’s team shared in a statement. ‘On Friday, he was diagnosed with prostate cancer, characterized by a Gleason score of 9 (Grade Group 5) with metastasis to the bone.’ 

‘While this represents a more aggressive form of the disease, the cancer appears to be hormone-sensitive which allows for effective management. The President and his family are reviewing treatment options with his physicians,’ the statement continued.

This is a developing story. Please check back for updates. 

Stepheny Price is a writer for Fox News Digital and Fox Business. She covers topics including missing persons, homicides, national crime cases, illegal immigration, and more. Story tips and ideas can be sent to stepheny.price@fox.com

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Johnson pushes ‘aggressive’ timetable for House to pass Trump’s budget bill after GOP mutiny: ‘We cannot fail’
next post
Trump wishes Biden ‘fast and successful recovery’ after prostate cancer diagnosis

You may also like

Trump wishes Biden ‘fast and successful recovery’ after...

May 18, 2025

Political world reacts to former President Biden’s ‘aggressive’...

May 18, 2025

Rubio teases details of potential Trump, Putin in-person...

May 18, 2025

Biden’s woes converge: Last-minute pardons under fire, calls...

May 18, 2025

Johnson pushes ‘aggressive’ timetable for House to pass...

May 18, 2025

Dems’ hearing meltdowns a play to the base,...

May 18, 2025

Republicans ready late-night session on Trump’s ‘big, beautiful...

May 18, 2025

DAVID MARCUS: Old Man Biden’s autopen pardons should...

May 18, 2025

Trump’s idea to make Americans have babies again...

May 18, 2025

WH study warns 9 million Americans could lose...

May 18, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!




    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Oil and natural gas: Oil is back on the positive side

    • 2

      The dollar index continues to pull back to a new low

    • 3

      Gold and Silver: Gold remains stable in the $2420 zone

    • 4

      IonQ Stock Review: Should You Consider Investing Now?

    • 5

      Bitcoin Rebounds to $83,404 Amid Renewed Investor Confidence

    Recent Posts

    • Political world reacts to former President Biden’s ‘aggressive’ cancer diagnosis: ‘Incredibly difficult’

      May 18, 2025
    • Trump wishes Biden ‘fast and successful recovery’ after prostate cancer diagnosis

      May 18, 2025
    • Joe Biden diagnosed with ‘aggressive form’ of prostate cancer with metastasis to the bone

      May 18, 2025
    • Rubio teases details of potential Trump, Putin in-person meeting after Russia-Ukraine ceasefire talks stall

      May 18, 2025
    • Johnson pushes ‘aggressive’ timetable for House to pass Trump’s budget bill after GOP mutiny: ‘We cannot fail’

      May 18, 2025

    Categories

    • Economy (20)
    • Editor's Pick (465)
    • Investing (68)
    • Stock (68)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 NewTradingView.com All Rights Reserved.


    Back To Top
    NewTradingView.com – Investing and Stock News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick